Navigation Links
H. D. Smith Promotes Leadership to Fill Two Senior Roles
Date:7/9/2009

SPRINGFIELD, Ill., July 9 /PRNewswire/ -- H. D. Smith recently announced the promotions of Jeff Greer to vice president of sales and Robert ("Bob") Dynek, Jr. to vice president of purchasing and trade relations. These appointments are the latest organizational announcement as the Company strengthens its senior leadership to maximize growth potential.

As vice president of sales, Greer will lead the Company's sales efforts to expand into new service sectors. In his new role as vice president of purchasing and trade relations, Dynek will have primary responsibility for purchasing and managing inventory service levels across all business segments consistent with company objectives of investment relative to vendor support and profit opportunities.

"Moving Jeff and Bob into corporate headquarters will take full advantage of growth potential for the Company," said Dale Smith, chairman and chief executive officer, H. D. Smith. "Together, they bring more than 50 years of expertise in pharmacy distribution and will be influential in helping us realize our goal of becoming the preferred pharmaceutical wholesaler nationwide."

Greer has more than 20 years of pharmacy sales and wholesale distribution experience. He joined H. D. Smith in 2005 as director of national accounts and most recently served as vice president division manager in H. D. Smith's Louisville, Kentucky facility. Greer joined the Company from AmerisourceBergen, a pharmaceutical services provider, holding roles of increasing responsibility including corporate vice president of strategic accounts and vice president and division manager for the southeast region. He studied at the University of Kentucky and is a military veteran.

Dynek joined H. D. Smith in 1998 and has served as director of vendor relations and manager of vendor relations and programs. During his time at H. D. Smith, Dynek's experience includes oversight and category management for the brand pharmaceuticals business segment, as well as day-to-day inventory management for the brand and generic pharmaceuticals business segments, representing over 95 percent of total company sales. Prior to joining H. D. Smith, Dynek served at General Drug Company, Foxmeyer Corporation and Louis Zahn Drug Company, all in a purchasing capacity. He received his Bachelor of Science in commerce from DePaul University.

About H. D. Smith

Headquartered in Springfield, Illinois, H. D. Smith is a national full-line, full-service wholesaler that provides a complete line of pharmaceuticals, OTCs, HBAs, HHC/DME products, seasonal merchandise and a wide array of marketing programs to retail, hospital and institutional pharmacies. The company has distribution facilities in California, Florida, Kentucky, Illinois, New Hampshire, New Jersey and Texas that service major markets throughout the United States. Additional information about H. D. Smith can be found at www.hdsmith.com.

    Contact:  Jill Loureiro
              Director of Marketing and Program Services
              H. D. Smith
              217-753-1688
              Jill.Loureiro@hdsmith.com

              Mark Marmur
              Makovsky + Co
              212-508-9670
              mmarmur@makovsky.com

'/>"/>
SOURCE H. D. Smith
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
2. GlaxoSmithKline Responds to JAMA Articles
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
5. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
6. TIGroup Names Dennis M. Smith as Chief Financial Officer
7. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
8. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
9. Smith & Nephew Endoscopys KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries
10. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
11. Smithfield(R) LEAN GENERATION(R) Announces DELI FOR THE CURE(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , ... with Age: The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp ... publication date is March 16, 2016. A free review copy is available to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined ... readily available to physicians. The integration will enable Allscripts users to post open ... Everseat’s free mobile app. , The partnership gives Everseat substantial added power to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... ... ... Anxiety of older Americans over steep cost increases of prescription drugs is at ... to The Senior Citizens League (TSCL). Since last fall, TSCL has ... costs. “The implications are chilling, particularly for people with chronic health problems,” says ...
(Date:2/10/2016)... ... 09, 2016 , ... Ross A. Clevens, MD, FACS ... welcome a new addition to their growing practice. Beginning this month, Teresa Imperiale-Westerfield, ... practitioner performing cosmetic procedures including injectables, fillers and laser treatments. A ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , February 9, 2016 ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QIAGEN N.V. (NASDAQ: ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... FRANCISCO , February 9, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, ... be a featured presenting company at Source Capital Group,s ... on February 10-11, 2016 in New York ... on Wednesday, February 10, 2016 at 12:30 pm by ...
Breaking Medicine Technology: